HKD 0.09
(-3.37%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 692.87 Million CNY | -13.08% |
2022 | 797.1 Million CNY | -18.96% |
2021 | 983.55 Million CNY | -14.56% |
2020 | 1.15 Billion CNY | -29.72% |
2019 | 1.63 Billion CNY | -28.12% |
2018 | 2.27 Billion CNY | 2.22% |
2017 | 2.22 Billion CNY | -32.5% |
2016 | 3.3 Billion CNY | 2.96% |
2015 | 3.2 Billion CNY | -6.03% |
2014 | 3.41 Billion CNY | 24.4% |
2013 | 2.74 Billion CNY | 81.12% |
2012 | 1.51 Billion CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 752.11 Million CNY | 0.0% |
2023 Q4 | 692.87 Million CNY | 0.0% |
2022 FY | 797.1 Million CNY | -18.96% |
2022 Q4 | 797.1 Million CNY | 0.0% |
2022 Q2 | 966.85 Million CNY | 0.0% |
2021 Q2 | 904.44 Million CNY | 0.0% |
2021 FY | 983.55 Million CNY | -14.56% |
2021 Q4 | 839.07 Million CNY | 0.0% |
2020 Q4 | 957.84 Million CNY | 0.0% |
2020 Q2 | 1.41 Billion CNY | 0.0% |
2020 FY | 1.15 Billion CNY | -29.72% |
2019 FY | 1.63 Billion CNY | -28.12% |
2019 Q4 | 1.49 Billion CNY | 0.0% |
2019 Q2 | 1.87 Billion CNY | 0.0% |
2018 FY | 2.27 Billion CNY | 2.22% |
2018 Q4 | 2 Billion CNY | 0.0% |
2018 Q2 | 2.09 Billion CNY | 0.0% |
2017 Q4 | 2.22 Billion CNY | 0.0% |
2017 Q2 | 2.58 Billion CNY | 0.0% |
2017 FY | 2.22 Billion CNY | -32.5% |
2016 Q4 | 3.21 Billion CNY | 0.0% |
2016 Q2 | 3.3 Billion CNY | 0.0% |
2016 FY | 3.3 Billion CNY | 2.96% |
2015 Q4 | 3.49 Billion CNY | 0.0% |
2015 FY | 3.2 Billion CNY | -6.03% |
2015 Q2 | 3.2 Billion CNY | 0.0% |
2014 FY | 3.41 Billion CNY | 24.4% |
2014 Q4 | 3.56 Billion CNY | 0.0% |
2014 Q2 | 3.41 Billion CNY | 0.0% |
2013 Q2 | 2.74 Billion CNY | 0.0% |
2013 FY | 2.74 Billion CNY | 81.12% |
2013 Q4 | 3.33 Billion CNY | 0.0% |
2012 FY | 1.51 Billion CNY | 0.0% |
2012 Q4 | 1.65 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
China Healthwise Holdings Limited | 149.67 Million HKD | -362.936% |
Tycoon Group Holdings Limited | 988.95 Million HKD | 29.938% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 4.43 Billion HKD | 84.375% |